Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 6/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.48 |
| ▸ | CYP8B1 | Q9UNU6 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5429391 | 1.00 | SLC2A1 (0.48) | SLC2A1KCNH2CYP8B1 | |
| SCHEMBL5426672 | 0.85 | KCNH2 (0.51) | SLC2A1KCNH2 | |
| SCHEMBL5429187 | 0.85 | KCNH2 (0.51) | SLC2A1KCNH2 | |
| SCHEMBL5434350 | 0.85 | KCNH2 (0.51) | SLC2A1KCNH2 | |
| SCHEMBL3696507 | 0.84 | KCNH2 (0.49) | SLC2A1KCNH2 | |
| SCHEMBL5435659 | 0.84 | KCNH2 (0.46) | SLC2A1KCNH2CYP8B1 | |
| SCHEMBL14357552 | 0.84 | KCNH2 (0.53) | SLC2A1KCNH2 | |
| SCHEMBL5258279 | 0.83 | KCNH2 (0.53) | SLC2A1KCNH2 | |
| SCHEMBL5315674 | 0.83 | KCNH2 (0.53) | SLC2A1KCNH2 | |
| SCHEMBL5447344 | 0.82 | KCNH2 (0.48) | SLC2A1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070254872-A1 | Antibacterial Agents | GLAXO GROUP LIMITED (GB) | 2007-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070254872-A1 | Antibacterial Agents | NQO2, NQO1, NDUFV2 | SLC2A1 4018/4885KCNH2 2586/4885CYP8B1 965/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.